. 2016 Feb 1;3(1):ofw022. doi: 10.1093/ofid/ofw022

Table 1.

Characteristics of HIV-Infected Study Population With Respect to Patients' Ability to Work at the Start of cART (n = 5800)

Characteristic at Baseline	100% Able to Work (N = 4382)		10%–90% Able to Work (N = 471)		0% Able to Work (N = 947)		P Value
Characteristic at Baseline	n	%	n	%	n	%	P Value
Median age, IQR	37	31–43	38	33–45	39	34–45	<.001
Male gender	3201	73.1	293	62.2	618	65.3	<.001
Transmission
MSM	2129	48.6	111	23.6	181	19.1	<.001^a
Heterosexual	1812	41.4	201	42.7	372	39.3
PWID	267	6.1	138	29.3	346	36.5
Other	174	4.0	21	4.5	48	5.1
White ethnicity	3210	73.3	379	80.5	773	81.6	<.001
Low educational attainment	994	22.9	163	35.9	325	36.1	<.001
Hepatitis C coinfection	786	17.9	191	40.6	452	47.3	<.001
Hepatitis B coinfection (antigen HBs positive)	224	5.1	20	4.3	62	6.6	.117
Prior AIDS-defining condition	532	12.1	120	25.5	354	37.8	<.001
Active injecting drug use	78	1.8	60	12.7	154	16.3	<.001
Opiate substitution program	280	6.4	83	17.6	249	26.3	<.001
Psychiatric disorder	229	5.2	66	14.0	186	19.6	<.001
Median HIV-RNA, IQR	4.7	4.1–5.2	4.8	3.9–5.3	4.9	4.2–5.5	<.001
Median CD4 cell count, IQR	263	160–372	196	65–325	157	54–291	<.001
CD4 cell count
<50	386	8.9	101	21.4	233	24.6	<.001^a
50–99	276	6.3	42	8.9	108	11.4
100–199	828	18.8	94	20.0	213	22.5
200–349	1621	37.0	135	28.7	225	23.7
>350	1271	29.0	99	21.0	168	17.8
cART
PI	2354	53.7	273	58.0	598	63.1	<.001^a
NNRTI	1735	39.6	155	32.9	284	30.0
Other	293	6.7	43	9.1	65	6.9
Time period
1998–2000	855	19.5	144	30.6	330	34.9	<.001^a
2001–2005	1133	25.9	164	34.8	292	30.8
2006–2012	2394	54.6	163	34.6	325	34.3

Abbreviations: AIDS, acquired immune deficiency syndrome; cART, combination antiretroviral therapy; HB, hepatitis B; HIV, human immunodeficiency virus; IQR, interquartile range; MSM, men who have sex with men; NNRTI, nonnucleoside reverse-transcriptase inhibitors; PI, boosted protease inhibitors; PWID, people who inject drugs; RNA, ribonucleic acid.

^a χ² test.